Search

everythinglearnresearchcommunity

for

Search:↓

A new method effectively predicts estrogen-related health effects for early screening.

Early diagnosis and personalized treatment are crucial for managing PCOS and preventing complications.

Polycystic Ovarian Syndrome (PCOS) is a common condition causing fertility issues and other symptoms, with unclear causes and treatments focused on improving insulin sensitivity.

L-Selectin and adiponectin can help identify PCOS patients who respond to Metformin treatment.

Combination therapy significantly reduces testosterone and moderately reduces hair growth in women with hirsutism.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

Cyproterone acetate therapy improved hair loss and reduced testosterone levels in a menopausal woman.

Cyproterone acetate effectively treats hirsutism and related conditions.

Routine genetic testing is crucial for early diagnosis and better management of Turner’s syndrome with 21-hydroxylase deficiency.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

Metformin helped improve the quality of life for Chinese women with PCOS, especially in physical health and symptoms like infertility, acne, and hair loss.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.

Some birth control pills can cause temporary or more serious hair loss.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

Women aged 21-26 have a higher rate of PCOS.

Buserelin safely and effectively suppresses early puberty, potentially improving final height.

Women with PCOS have higher levels of certain hormones compared to healthy women, and these levels vary with BMI, age, and treatment type.

A new method was developed to make a compound used in finasteride and epristeride with a 69% yield.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

Ciclosporin can cause excessive hair growth even with testosterone blockers.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

The treatment improved menstrual flow and reduced ovarian cysts in mild to moderate PCOS cases.